1-10 of 10
Shili Xu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 554: Histone deacetylase inhibition is synthetically lethal with arginine deprivation in pancreatic cancers with low argininosuccinate synthetase 1 expression

Free
Stephanie S Kim, JING CUI, Shili Xu, Soumya Poddar, Thuc M. Le, Luyi Li, Nanping Wu, Alexandra Moore, Lei Zhou, Alice Yu, Amanda M. Dann, Irmina A. Elliott, Evan R. Abt, Woosuk Kim, David W. Dawson, Caius G. Radu, Timothy R. Donahue
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 554.
https://doi.org/10.1158/1538-7445.AM2020-554
Published: 15 August 2020
View articletitled, Abstract 554: Histone deacetylase inhibition is synthetically lethal with arginine deprivation in pancreatic cancers with low argininosuccinate synthetase 1 expression
Journal Articles

Abstract 6045: Interferon signaling induces NAD(H) consumption via PARP9/10/14 and sensitizes pancreatic cancer cells to NAMPT inhibition

Free
Alexandra M. Moore, Lei Zhou, Shili Xu, Timothy R. Donahue
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 6045.
https://doi.org/10.1158/1538-7445.AM2020-6045
Published: 15 August 2020
View articletitled, Abstract 6045: Interferon signaling induces NAD(H) consumption via PARP9/10/14 and sensitizes pancreatic cancer cells to NAMPT inhibition
Journal Articles

A Tumor Agnostic Therapeutic Strategy for Hexokinase 1–Null/Hexokinase 2–Positive Cancers

Free
Shili Xu, Harvey R. Herschman
Journal: Cancer Research
Cancer Res (2019) 79 (23): 5907–5914.
https://doi.org/10.1158/0008-5472.CAN-19-1789
Published: 02 December 2019
View articletitled, A Tumor Agnostic Therapeutic Strategy for Hexokinase 1–Null/Hexokinase 2–Positive Cancers
Open the PDF for A Tumor Agnostic Therapeutic Strategy for Hexokinase 1–Null/Hexokinase 2–Positive Cancers in another window
Journal Articles

Abstract 4264: Lysosome inhibition sensitizes pancreatic cancer to replication stress by aspartate depletion

Free
Shili Xu, Irmina A. Elliott, Amanda M. Dann, Stephanie S. Kim, Evan R. Abe, Woosuk Kim, Soumya Poddar, Alexandra Moore, Lei Zhou, Jennifer L. Williams, Joseph R. Capri, Razmik Ghukasyan, Cynthia Matsumura, D. Andrew Tucker, Wesley R. Armstrong, Anthony E. Cabebe, Nanping Wu, Luyi Li, Thuc M. Le, Caius G. Radu, Timothy R. Donahue
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 4264.
https://doi.org/10.1158/1538-7445.AM2019-4264
Published: 01 July 2019
View articletitled, Abstract 4264: Lysosome inhibition sensitizes pancreatic cancer to replication stress by aspartate depletion
Journal Articles

An HK2 Antisense Oligonucleotide Induces Synthetic Lethality in HK1−HK2+ Multiple Myeloma

Free
Shili Xu, Tianyuan Zhou, Hanna M. Doh, K Ryan Trinh, Art Catapang, Jason T. Lee, Daniel Braas, Nicholas A. Bayley, Reiko E. Yamada, Alex Vasuthasawat, Joshua P. Sasine, John M. Timmerman, Sarah M. Larson, Youngsoo Kim, A. Robert MacLeod, Sherie L. Morrison, Harvey R. Herschman
Journal: Cancer Research
Cancer Res (2019) 79 (10): 2748–2760.
https://doi.org/10.1158/0008-5472.CAN-18-2799
Published: 15 May 2019
View articletitled, An HK2 Antisense Oligonucleotide Induces Synthetic Lethality in HK1−HK2+ Multiple Myeloma
Open the PDF for An HK2 Antisense Oligonucleotide Induces Synthetic Lethality in HK1−HK2+ Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

Abstract 4466: New biomarkers to optimize preclinical development of the PDI inhibitor XCE853

Free
Gregoire Pierre Prevost, Marine Garrido, Shili Xu, Celine Lefebvre, Anne Chauchereau, Denis Carniato, Jean François Briand, Mathieu Gutmann, Maria Serova, Annemilai Tijeras-Raballand, Armand De Grammont, Eric Raymond, Christian Gespach, Michèle Sabbah, Nouri Neamati, Marc-Henry Pitty, Paul Foster
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 4466.
https://doi.org/10.1158/1538-7445.AM2015-4466
Published: 01 August 2015
View articletitled, Abstract 4466: New biomarkers to optimize preclinical development of the PDI inhibitor XCE853
Journal Articles

Abstract 1812: XCE853: A novel PDI inhibitor that inhibits proliferation of human tumor cells in vitro, ex-vivo and in vivo

Free
Gregoire P. Prevost, Shili Xu, Marine Garrido, Maria Serova, Olivier D. Vewer, Christian Gespach, Jean-François Briand, Annemilaï Tijeras-Raballand, Mathieu Gutmann, An Hendrix, Michele Sabbah, Anne Chachereau, Armand de Gramont, Nouri Neamati, Denis Carniato, Marc-Henry Pitty, Paul Foster
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 1812.
https://doi.org/10.1158/1538-7445.AM2014-1812
Published: 01 October 2014
View articletitled, Abstract 1812: XCE853: A novel PDI inhibitor that inhibits proliferation of human tumor cells in vitro, ex-vivo and in vivo
Journal Articles

Abstract 5513: Discovery of an orally active small-molecule irreversible inhibitor of protein disulfide isomerase (PDI) for ovarian cancer treatment.

Free
Shili Xu, Alexey N. Butkevich, Roppei Yamada, Yu Zhou, Bikash Debnath, Roger Duncan, Ebrahim Zandi, Nicos A. Petasis, Nouri Neamati
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 5513.
https://doi.org/10.1158/1538-7445.AM2013-5513
Published: 15 April 2013
View articletitled, Abstract 5513: Discovery of an orally active small-molecule irreversible inhibitor of protein disulfide isomerase (PDI) for ovarian cancer treatment.
Journal Articles

Abstract 1927: Mechanistic characterization of SC144 in colon cancer

Free
Shili Xu, Takashi Oshima, Fedora Grande, Nouri Neamati, Antonio Garofalo
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 1927.
https://doi.org/10.1158/1538-7445.AM2012-1927
Published: 15 April 2012
View articletitled, Abstract 1927: Mechanistic characterization of SC144 in colon cancer
Journal Articles

Abstract 2908: Biological evaluation of paclitaxel-peptide conjugates as a model for MMP2-targeted drug delivery

Free
Roppei Yamada, Shili Xu, Nouri Neamati
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 2908.
https://doi.org/10.1158/1538-7445.AM2012-2908
Published: 15 April 2012
View articletitled, Abstract 2908: Biological evaluation of paclitaxel-peptide conjugates as a model for MMP2-targeted drug delivery